StepStone Group’s Repare Therapeutics RPTX Stock Holding History

StepStone Group’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,721	Closed	-$268K	–	4
2021 Q1	$268K	Buy	+8,721	New	+$296K	4.12%	5

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

StepStone Group's RPTX Position: Q2 2021 in Review

StepStone Group sold out of Repare Therapeutics (RPTX) in Q2 2021, closing a stake of 8,721 shares — an estimated $268K sold.

StepStone Group first reported a position in RPTX in Q1 2021 and held it in 1 quarter. The position peaked at $268K in Q1 2021. 61 funds tracked by Wall St. Rank hold RPTX as of Q2 2021.

StepStone Group reported no remaining Repare Therapeutics position as of Q2 2021 after selling out during the quarter.
StepStone Group sold 8,721 Repare Therapeutics shares in Q2 2021, an estimated $268K.
StepStone Group first reported a position in Repare Therapeutics in Q1 2021 and held it in 1 quarter.
StepStone Group's Repare Therapeutics position peaked at $268K in Q1 2021.
61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2021.

Based on StepStone Group's 13F filing for Q2 2021, filed 13 Aug 2021.